Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Hydbring

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Nature Reviews. Molecular Cell Biology|April 2, 2016
Non-canonical functions of cell cycle cyclins and cyclin-dependent kinasesPer Hydbring, Marcos Malumbres, Piotr Sicinski
Genes|July 1, 2017
MYC Modulation around the CDK2/p27/SKP2 AxisPer Hydbring, Alina Castell, Lars-Gunnar Larsson
Drug Discovery Today|April 9, 2017
Nanoparticles for immune system targetingJuan Du, Yu Shrike Zhang, Divia Hobson, et al.
Experimental Cell Research|September 22, 2009
TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activitySiqin Wu, Anne Hultquist, Per Hydbring, et al.
Oncotarget|November 23, 2017
MYC is downregulated by a mitochondrial checkpoint mechanismXiaonan Zhang, Arjan Mofers, Per Hydbring, et al.
Cell Cycle (Georgetown, Tex.)|November 4, 2017
Identification of cell cycle-targeting microRNAs through genome-wide screensPer Hydbring, Yinan Wang, Roman L Bogorad, et al.
Translational Lung Cancer Research|September 12, 2022
Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohortQing Wang, Yansu Wang, Xinyu Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2011
The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loopAntje Menssen, Per Hydbring, Karsten Kapelle, et al.
Cell Reports|June 15, 2017
PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor PrognosisBoxi Zhang, Adi Zheng, Per Hydbring, et al.
Cell Cycle (Georgetown, Tex.)|December 28, 2020
Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescenceWesam Bazzar, Matteo Bocci, Eduar Hejll, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Nature Reviews. Molecular Cell Biology|April 2, 2016
Non-canonical functions of cell cycle cyclins and cyclin-dependent kinasesPer Hydbring, Marcos Malumbres, Piotr Sicinski
Genes|July 1, 2017
MYC Modulation around the CDK2/p27/SKP2 AxisPer Hydbring, Alina Castell, Lars-Gunnar Larsson
Drug Discovery Today|April 9, 2017
Nanoparticles for immune system targetingJuan Du, Yu Shrike Zhang, Divia Hobson, et al.
Experimental Cell Research|September 22, 2009
TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activitySiqin Wu, Anne Hultquist, Per Hydbring, et al.
Oncotarget|November 23, 2017
MYC is downregulated by a mitochondrial checkpoint mechanismXiaonan Zhang, Arjan Mofers, Per Hydbring, et al.
Cell Cycle (Georgetown, Tex.)|November 4, 2017
Identification of cell cycle-targeting microRNAs through genome-wide screensPer Hydbring, Yinan Wang, Roman L Bogorad, et al.
Translational Lung Cancer Research|September 12, 2022
Development and validation of a dynamic survival nomogram for metastatic non-small cell lung cancer based on the SEER database and an external validation cohortQing Wang, Yansu Wang, Xinyu Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2011
The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loopAntje Menssen, Per Hydbring, Karsten Kapelle, et al.
Cell Reports|June 15, 2017
PHGDH Defines a Metabolic Subtype in Lung Adenocarcinomas with Poor PrognosisBoxi Zhang, Adi Zheng, Per Hydbring, et al.
Cell Cycle (Georgetown, Tex.)|December 28, 2020
Pharmacological inactivation of CDK2 inhibits MYC/BCL-XL-driven leukemia in vivo through induction of cellular senescenceWesam Bazzar, Matteo Bocci, Eduar Hejll, et al.
Pageof 5